Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Clinical significance of subcutaneous fat and fascial involvement in juvenile dermatomyositis.

Sakurai N, Hino-Shishikura A, Nozawa T, Kamide H, Ohara A, Nishimura K, Kikuchi M, Hara R, Mori M, Ito S.

Mod Rheumatol. 2018 Aug 10:1-16. doi: 10.1080/14397595.2018.1511026. [Epub ahead of print]

PMID:
30092673
2.

Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice.

Ohara A, Takahashi Y, Kondo M, Okuda Y, Takeda S, Kushida M, Kobayashi K, Sumida K, Yamada T.

Toxicol Res (Camb). 2017 Aug 24;6(6):795-813. doi: 10.1039/c7tx00163k. eCollection 2017 Nov 1.

PMID:
30090543
3.

Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Jul 30. doi: 10.1007/s10147-018-1323-2. [Epub ahead of print]

PMID:
30062493
4.

Specific alteration of gene expression profile in rats by treatment with thyroid toxicants that inhibit thyroid hormone synthesis.

Ohara A, Yamada F, Fukuda T, Suzuki N, Sumida K.

J Appl Toxicol. 2018 Jul 25. doi: 10.1002/jat.3693. [Epub ahead of print]

PMID:
30047161
5.

Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3.

Hiejima E, Shibata H, Yasumi T, Shimodera S, Hori M, Izawa K, Kawai T, Matsuoka M, Kojima Y, Ohara A, Nishikomori R, Ohara O, Heike T.

Clin Immunol. 2018 Jun;191:63-66. doi: 10.1016/j.clim.2018.03.012. Epub 2018 Mar 26.

PMID:
29596912
6.

Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.

Takahashi H, Kajiwara R, Kato M, Hasegawa D, Tomizawa D, Noguchi Y, Koike K, Toyama D, Yabe H, Kajiwara M, Fujimura J, Sotomatsu M, Ota S, Maeda M, Goto H, Kato Y, Mori T, Inukai T, Shimada H, Fukushima K, Ogawa C, Makimoto A, Fukushima T, Ohki K, Koh K, Kiyokawa N, Manabe A, Ohara A.

Int J Hematol. 2018 Jul;108(1):98-108. doi: 10.1007/s12185-018-2440-4. Epub 2018 Mar 27.

PMID:
29589281
7.

Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese.

Urayama KY, Takagi M, Kawaguchi T, Matsuo K, Tanaka Y, Ayukawa Y, Arakawa Y, Hasegawa D, Yuza Y, Kaneko T, Noguchi Y, Taneyama Y, Ota S, Inukai T, Yanagimachi M, Keino D, Koike K, Toyama D, Nakazawa Y, Kurosawa H, Nakamura K, Moriwaki K, Goto H, Sekinaka Y, Morita D, Kato M, Takita J, Tanaka T, Inazawa J, Koh K, Ishida Y, Ohara A, Mizutani S, Matsuda F, Manabe A.

Sci Rep. 2018 Jan 15;8(1):789. doi: 10.1038/s41598-017-19127-7.

8.

Live-attenuated vaccines in a cryopyrin-associated periodic syndrome patient receiving canakinumab treatment during infancy.

Watanabe M, Nishikomori R, Fujimaki Y, Heike T, Ohara A, Saji T.

Clin Case Rep. 2017 Sep 12;5(11):1750-1755. doi: 10.1002/ccr3.1149. eCollection 2017 Nov.

9.

[Disorder of Gastric Myoelectric Activity in Patients with Cerebral Infarction:Electrogastrographic Assessment].

Kinekawa F, Sasaoka N, Matsuda K, Kita Y, Okura R, Nakabayashi R, Ohara A, Nakao K, Inoue T, Tokuda M, Kokudo Y, Masaki T.

No Shinkei Geka. 2017 Jul;45(7):575-582. doi: 10.11477/mf.1436203554. Japanese.

PMID:
28720739
10.

A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.

Chihara Y, Shimoda M, Hori A, Ohara A, Naoi Y, Ikeda JI, Kagara N, Tanei T, Shimomura A, Shimazu K, Kim SJ, Noguchi S.

Breast Cancer Res Treat. 2017 Nov;166(1):55-68. doi: 10.1007/s10549-017-4382-6. Epub 2017 Jul 12.

PMID:
28702892
11.

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.

Seki M, Kimura S, Isobe T, Yoshida K, Ueno H, Nakajima-Takagi Y, Wang C, Lin L, Kon A, Suzuki H, Shiozawa Y, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Shimamura T, Masuda K, Kawamoto H, Ohki K, Kato M, Arakawa Y, Koh K, Hanada R, Moritake H, Akiyama M, Kobayashi R, Deguchi T, Hashii Y, Imamura T, Sato A, Kiyokawa N, Oka A, Hayashi Y, Takagi M, Manabe A, Ohara A, Horibe K, Sanada M, Iwama A, Mano H, Miyano S, Ogawa S, Takita J.

Nat Genet. 2017 Aug;49(8):1274-1281. doi: 10.1038/ng.3900. Epub 2017 Jul 3.

PMID:
28671687
12.

A Proinflammatory Effect of the β-Glucan from Pleurotus cornucopiae Mushroom on Macrophage Action.

Minato KI, Ohara A, Mizuno M.

Mediators Inflamm. 2017;2017:8402405. doi: 10.1155/2017/8402405. Epub 2017 May 15.

13.

Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan.

Ogawa C, Taguchi F, Goto H, Koh K, Tomizawa D, Ohara A, Manabe A.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26475. Epub 2017 Feb 28.

PMID:
28244643
14.

Exome sequencing identified RPS15A as a novel causative gene for Diamond-Blackfan anemia.

Ikeda F, Yoshida K, Toki T, Uechi T, Ishida S, Nakajima Y, Sasahara Y, Okuno Y, Kanezaki R, Terui K, Kamio T, Kobayashi A, Fujita T, Sato-Otsubo A, Shiraishi Y, Tanaka H, Chiba K, Muramatsu H, Kanno H, Ohga S, Ohara A, Kojima S, Kenmochi N, Miyano S, Ogawa S, Ito E.

Haematologica. 2017 Mar;102(3):e93-e96. doi: 10.3324/haematol.2016.153932. Epub 2016 Dec 1. No abstract available.

15.

New possible biomarkers for diagnosis of infections and diagnostic distinction between bacterial and viral infections in children.

Yusa T, Tateda K, Ohara A, Miyazaki S.

J Infect Chemother. 2017 Feb;23(2):96-100. doi: 10.1016/j.jiac.2016.11.002. Epub 2016 Nov 25.

16.

Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.

Nozawa T, Nishimura K, Ohara A, Hara R, Ito S.

Mod Rheumatol. 2016 Dec 14:1-5. [Epub ahead of print]

PMID:
27846755
17.

Vitrectomy and scleral imbrication in patients with myopic traction maculopathy and macular hole retinal detachment.

Ando Y, Hirakata A, Ohara A, Yokota R, Orihara T, Hirota K, Koto T, Inoue M.

Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):673-680. doi: 10.1007/s00417-016-3523-7. Epub 2016 Nov 10.

18.

Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.

Nishikawa E, Yagasaki H, Hama A, Yabe H, Ohara A, Kosaka Y, Kudo K, Kobayashi R, Ohga S, Morimoto A, Watanabe KI, Yoshida N, Muramatsu H, Takahashi Y, Kojima S.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26305. Epub 2016 Nov 3.

PMID:
27808465
19.

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.

Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K, Kakiuchi N, Sato Y, Ueno H, Tanaka H, Inukai T, Tomizawa D, Hasegawa D, Osumi T, Arakawa Y, Aoki T, Okuya M, Kaizu K, Kato K, Taneyama Y, Goto H, Taki T, Takagi M, Sanada M, Koh K, Takita J, Miyano S, Ogawa S, Ohara A, Tsuchida M, Manabe A.

Leukemia. 2017 Mar;31(3):580-584. doi: 10.1038/leu.2016.274. Epub 2016 Oct 4.

PMID:
27698447
20.

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yaguchi A, Terada K, Saito Y, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fujimura J, Hino M, Kinoshita A, Kakuda H, Kurosawa H, Kato K, Kajiwara R, Moriwaki K, Morimoto T, Nakamura K, Noguchi Y, Osumi T, Sakashita K, Takita J, Yuza Y, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Fukushima T, Koh K, Manabe A, Ohara A, Kiyokawa N; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2017 Jan;102(1):118-129. doi: 10.3324/haematol.2016.151035. Epub 2016 Sep 15.

21.

Pleurotus citrinopileatus polysaccharide induces activation of human dendritic cells through multiple pathways.

Minato KI, Laan LC, Ohara A, van Die I.

Int Immunopharmacol. 2016 Nov;40:156-163. doi: 10.1016/j.intimp.2016.08.034. Epub 2016 Sep 1.

PMID:
27592080
22.

Erythrocyte glutathione is a novel biomarker of Diamond-Blackfan anemia.

Utsugisawa T, Uchiyama T, Toki T, Ogura H, Aoki T, Hamaguchi I, Ishiguro A, Ohara A, Kojima S, Ohga S, Ito E, Kanno H.

Blood Cells Mol Dis. 2016 Jul;59:31-6. doi: 10.1016/j.bcmd.2016.03.007. Epub 2016 Apr 11.

PMID:
27282564
23.

Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.

Imamura T, Kiyokawa N, Kato M, Imai C, Okamoto Y, Yano M, Ohki K, Yamashita Y, Kodama Y, Saito A, Mori M, Ishimaru S, Deguchi T, Hashii Y, Shimomura Y, Hori T, Kato K, Goto H, Ogawa C, Koh K, Taki T, Manabe A, Sato A, Kikuta A, Adachi S, Horibe K, Ohara A, Watanabe A, Kawano Y, Ishii E, Shimada H.

Blood Cancer J. 2016 May 13;6:e419. doi: 10.1038/bcj.2016.28.

24.

Formal Total Synthesis of (±)-Strictamine Based on a Gold-Catalyzed Cyclization.

Nishiyama D, Ohara A, Chiba H, Kumagai H, Oishi S, Fujii N, Ohno H.

Org Lett. 2016 Apr 1;18(7):1670-3. doi: 10.1021/acs.orglett.6b00536. Epub 2016 Mar 24.

PMID:
27011119
25.

Detecting central-venous oxygen desaturation without a central-venous catheter: Utility of the difference between invasively and noninvasively measured blood pressure.

Kumasawa J, Ohara A, Kohata H, Aoyagi K, Fukuma S, Fukuhara S.

J Crit Care. 2016 Jun;33:257-61. doi: 10.1016/j.jcrc.2016.02.022. Epub 2016 Mar 2.

PMID:
26994778
26.

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Keino D, Kinoshita A, Tomizawa D, Takahashi H, Ida K, Kurosawa H, Koike K, Ota S, Iwasaki N, Fujimura J, Yuza Y, Kiyotani C, Yamamoto S, Osumi T, Ueda T, Mochizuki S, Isoyama K, Hanada R, Tawa A, Manabe A, Toguchi Y, Ohara A.

Int J Hematol. 2016 Apr;103(4):416-22. doi: 10.1007/s12185-016-1937-y. Epub 2016 Jan 18.

PMID:
26781613
27.

ALDH2 polymorphism in patients with Diamond-Blackfan anemia in Japan.

Ikeda F, Toki T, Kanezaki R, Terui K, Yoshida K, Kanno H, Ohga S, Ohara A, Kojima S, Ogawa S, Ito E.

Int J Hematol. 2016 Jan;103(1):112-4. doi: 10.1007/s12185-015-1891-0. Epub 2015 Nov 25. No abstract available.

PMID:
26608366
28.

Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.

Tomizawa D, Kato M, Takahashi H, Fujimura J, Inukai T, Fukushima T, Kiyokawa N, Koh K, Manabe A, Ohara A.

Int J Hematol. 2015 Nov;102(5):602-10. doi: 10.1007/s12185-015-1869-y. Epub 2015 Sep 26.

PMID:
26410102
29.

Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Narita A, Muramatsu H, Sekiya Y, Okuno Y, Sakaguchi H, Nishio N, Yoshida N, Wang X, Xu Y, Kawashima N, Doisaki S, Hama A, Takahashi Y, Kudo K, Moritake H, Kobayashi M, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S; Japan Childhood Aplastic Anemia Study Group.

Haematologica. 2015 Dec;100(12):1546-52. doi: 10.3324/haematol.2015.132530. Epub 2015 Aug 27.

30.

Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.

Hama A, Takahashi Y, Muramatsu H, Ito M, Narita A, Kosaka Y, Tsuchida M, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S.

Haematologica. 2015 Nov;100(11):1426-33. doi: 10.3324/haematol.2015.128553. Epub 2015 Aug 13.

31.

A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

Gocho Y, Kiyokawa N, Ichikawa H, Nakabayashi K, Osumi T, Ishibashi T, Ueno H, Terada K, Oboki K, Sakamoto H, Shioda Y, Imai M, Noguchi Y, Arakawa Y, Kojima Y, Toyama D, Hata K, Yoshida T, Matsumoto K, Kato M, Fukushima T, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group.

Leukemia. 2015 Dec;29(12):2445-8. doi: 10.1038/leu.2015.111. Epub 2015 May 6. No abstract available.

PMID:
25943178
32.

Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.

Piao YS, Hall FS, Moriya Y, Ito M, Ohara A, Kikura-Hanajiri R, Goda Y, Lesch KP, Murphy DL, Uhl GR, Sora I.

Behav Pharmacol. 2015 Jun;26(4):345-52. doi: 10.1097/FBP.0000000000000135.

PMID:
25794333
33.

Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).

Kato M, Manabe A, Saito AM, Koh K, Inukai T, Ogawa C, Goto H, Tsuchida M, Ohara A.

Int J Hematol. 2015 Jan;101(1):52-7. doi: 10.1007/s12185-014-1710-z. Epub 2014 Nov 29.

PMID:
25432437
34.

Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia.

Wang R, Yoshida K, Toki T, Sawada T, Uechi T, Okuno Y, Sato-Otsubo A, Kudo K, Kamimaki I, Kanezaki R, Shiraishi Y, Chiba K, Tanaka H, Terui K, Sato T, Iribe Y, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Hara J, Goi K, Matsubara K, Koike K, Ishiguro A, Okamoto Y, Watanabe K, Kanno H, Kojima S, Miyano S, Kenmochi N, Ogawa S, Ito E.

Br J Haematol. 2015 Mar;168(6):854-64. doi: 10.1111/bjh.13229. Epub 2014 Nov 25.

PMID:
25424902
35.

TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation.

Kobayashi K, Miyagawa N, Mitsui K, Matsuoka M, Kojima Y, Takahashi H, Ootsubo K, Nagai J, Ueno H, Ishibashi T, Sultana S, Okada Y, Akimoto S, Okita H, Matsumoto K, Goto H, Kiyokawa N, Ohara A.

Pediatr Blood Cancer. 2015 Jun;62(6):1058-60. doi: 10.1002/pbc.25327. Epub 2014 Nov 14.

PMID:
25400122
36.

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.

Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K, Kudo K, Morimoto A, Ohga S, Muramatsu H, Takahashi Y, Kato K, Suzuki R, Ohara A, Kojima S.

Haematologica. 2014 Dec;99(12):1784-91. doi: 10.3324/haematol.2014.109355. Epub 2014 Sep 5.

37.

[A case of atypical hemolytic uremic syndrome successfully weaned from plasma exchange by treatment with eculizumab].

Nagata A, Ohara A, Wakasugi D, Natori C, Ito S, Taguchi K, Fukami K, Okuda S.

Nihon Jinzo Gakkai Shi. 2014;56(5):606-11. Japanese.

PMID:
25130033
38.

Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.

Kato M, Manabe A, Koh K, Inukai T, Kiyokawa N, Fukushima T, Goto H, Hasegawa D, Ogawa C, Koike K, Ota S, Noguchi Y, Kikuchi A, Tsuchida M, Ohara A.

Int J Hematol. 2014 Aug;100(2):180-7. doi: 10.1007/s12185-014-1622-y. Epub 2014 Jun 18.

PMID:
24938380
39.

Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.

Sakaguchi H, Nishio N, Hama A, Kawashima N, Wang X, Narita A, Doisaki S, Xu Y, Muramatsu H, Yoshida N, Takahashi Y, Kudo K, Moritake H, Nakamura K, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S; Japan Childhood Aplastic Anemia Study Group.

Haematologica. 2014 Aug;99(8):1312-6. doi: 10.3324/haematol.2013.091165. Epub 2014 May 9.

40.

Prognostic impact of gained chromosomes in high-hyperdiploid childhood acute lymphoblastic leukaemia: a collaborative retrospective study of the Tokyo Children's Cancer Study Group and Japan Association of Childhood Leukaemia Study.

Kato M, Imamura T, Manabe A, Hashii Y, Koh K, Sato A, Takahashi H, Hori H, Taki T, Inoue M, Hayashi Y, Horibe K, Tsuchida M, Kojima S, Oda M, Ohara A.

Br J Haematol. 2014 Jul;166(2):295-8. doi: 10.1111/bjh.12836. Epub 2014 Mar 17. No abstract available.

PMID:
24628674
41.

ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.

Kobayashi K, Mitsui K, Ichikawa H, Nakabayashi K, Matsuoka M, Kojima Y, Takahashi H, Iijima K, Ootsubo K, Oboki K, Okita H, Yasuda K, Sakamoto H, Hata K, Yoshida T, Matsumoto K, Kiyokawa N, Ohara A.

Br J Haematol. 2014 Jun;165(6):836-41. doi: 10.1111/bjh.12834. Epub 2014 Mar 15.

PMID:
24628626
42.

[Case report; A case of filarial chyluria with severe hypoproteinemia].

Ito S, Natori C, Nagata A, Ohara A.

Nihon Naika Gakkai Zasshi. 2013 Dec 10;102(12):3227-9. Japanese. No abstract available.

PMID:
24605574
43.

Pain management during bone marrow aspiration and biopsy in pediatric cancer patients.

Kato Y, Maeda M, Aoki Y, Ishii E, Ishida Y, Kiyotani C, Goto S, Sakaguchi S, Sugita K, Tokuyama M, Nakadate H, Kikuchi A, Tsuchida M, Ohara A.

Pediatr Int. 2014 Jun;56(3):354-9. doi: 10.1111/ped.12283.

PMID:
24417881
44.

Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.

Yagasaki H, Shichino H, Ohara A, Kobayashi R, Yabe H, Ohga S, Hamamoto K, Ohtsuka Y, Shimada H, Inoue M, Muramatsu H, Takahashi Y, Kojima S.

Ann Hematol. 2014 May;93(5):747-52. doi: 10.1007/s00277-013-1984-x. Epub 2013 Dec 14.

PMID:
24337487
45.

Significance of CD66c expression in childhood acute lymphoblastic leukemia.

Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara M, Shimada H, Inukai T, Makimoto A, Fukushima T, Nanmoku T, Koh K, Manabe A, Kikuchi A, Sugita K, Fujimoto J, Hayashi Y, Ohara A.

Leuk Res. 2014 Jan;38(1):42-8. doi: 10.1016/j.leukres.2013.10.008. Epub 2013 Oct 22.

PMID:
24231528
46.

Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.

Jeong DC, Chung NG, Cho B, Zou Y, Ruan M, Takahashi Y, Muramatsu H, Ohara A, Kosaka Y, Yang W, Kim HK, Zhu X, Kojima S.

Haematologica. 2014 Apr;99(4):664-71. doi: 10.3324/haematol.2013.089268. Epub 2013 Nov 8.

47.

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.

Kato M, Koh K, Manabe A, Saito T, Hasegawa D, Isoyama K, Kinoshita A, Maeda M, Okimoto Y, Kajiwara M, Kaneko T, Sugita K, Kikuchi A, Tsuchida M, Ohara A.

Br J Haematol. 2014 Feb;164(3):376-83. doi: 10.1111/bjh.12632. Epub 2013 Oct 26.

PMID:
24164537
48.

Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.

Ishida Y, Maeda M, Urayama KY, Kiyotani C, Aoki Y, Kato Y, Goto S, Sakaguchi S, Sugita K, Tokuyama M, Nakadate N, Ishii E, Tsuchida M, Ohara A; QOL committee of Tokyo Children's Cancer Study Group (TCCSG).

Br J Haematol. 2014 Jan;164(1):101-12. doi: 10.1111/bjh.12602. Epub 2013 Oct 10.

PMID:
24116892
49.

Function of a glutamine synthetase-like protein in bacterial aniline oxidation via γ-glutamylanilide.

Takeo M, Ohara A, Sakae S, Okamoto Y, Kitamura C, Kato D, Negoro S.

J Bacteriol. 2013 Oct;195(19):4406-14. doi: 10.1128/JB.00397-13. Epub 2013 Jul 26.

50.

Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.

Horibe K, Saito AM, Takimoto T, Tsuchida M, Manabe A, Shima M, Ohara A, Mizutani S.

Int J Hematol. 2013 Jul;98(1):74-88. doi: 10.1007/s12185-013-1364-2. Epub 2013 May 24.

PMID:
23702913

Supplemental Content

Support Center